We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.99%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$102B
AUM Growth
+$3.72B
(+3.8%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.18%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
266
New
6
Increased
123
Reduced
91
Closed
9
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetApp
NTAP
|
+$584M |
| 2 |
American Airlines Group
AAL
|
+$149M |
| 3 |
JPMorgan Chase
JPM
|
+$148M |
| 4 |
Eli Lilly
LLY
|
+$132M |
| 5 |
Ericsson
ERIC
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$241M |
| 2 |
AbbVie
ABBV
|
+$172M |
| 3 |
Electronic Arts
EA
|
+$124M |
| 4 |
Adobe
ADBE
|
+$120M |
| 5 |
Intuit
INTU
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.02% |
| 2 | Technology | 26.82% |
| 3 | Industrials | 14.67% |
| 4 | Consumer Discretionary | 8.41% |
| 5 | Miscellaneous | 6.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Edwards Lifesciences
EW
$50.8B
| $39.9M | 0.04% |
1,680,000
| – | – |
2013 Q2
7 quarters
|
|
177
DELISTED
Du Pont De Nemours E I
DD
| $34.5M | 0.03% |
507,967
-158,161
| -24% | -$11.3M |
2013 Q2
7 quarters
|
|
178
Stratasys
SSYS
$624M
| $34M | 0.03% |
645,000
-3,600
| -0.6% | -$238K |
2013 Q2
7 quarters
|
|
|
SZYM
179
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $34M | 0.03% |
11,891,709
-1,000
| -0% | -$2.56K |
2013 Q2
7 quarters
|
|
180
Cerus
CERS
$455M
| $30.4M | 0.03% |
+7,300,000
| New | +$37.4M |
2015 Q1
0 quarters
|
|
181
Chegg
CHGG
$84.4M
| $30.3M | 0.03% |
3,807,790
+1,015,620
| +36% | +$7.54M |
2014 Q1
4 quarters
|
|
|
UTIW
182
DELISTED
UTI WORLDWIDE INC
UTIW
| $30.1M | 0.03% |
2,445,000
+140,500
| +6% | +$1.74M |
2014 Q2
3 quarters
|
|
183
Axcelis
ACLS
$3.55B
| $29.4M | 0.03% |
3,085,500
| – | – |
2014 Q1
4 quarters
|
|
184
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $28.4M | 0.03% |
630,200
-691,100
| -52% | -$31.5M |
2013 Q2
7 quarters
|
|
185
Stryker
SYK
$112B
| $27.3M | 0.03% |
295,500
-9,000
| -3% | -$838K |
2013 Q2
7 quarters
|
|
|
SREV
186
DELISTED
ServiceSource International, Inc.
SREV
| $26.8M | 0.03% |
8,634,700
| – | – |
2014 Q1
4 quarters
|
|
187
DELISTED
PALL CORP
PLL
| $24.6M | 0.02% |
245,000
| – | – |
2013 Q2
7 quarters
|
|
188
Tyson Foods
TSN
$19B
| $24.3M | 0.02% |
635,000
+575,000
| +958% | +$23M |
2014 Q4
1 quarter
|
|
|
GUID
189
DELISTED
Guidance Software, Inc.
GUID
| $24.1M | 0.02% |
4,451,707
+505,463
| +13% | +$3.1M |
2013 Q2
7 quarters
|
|
|
XOOM
190
DELISTED
XOOM CORP COM
XOOM
| $22.6M | 0.02% |
1,539,800
-78,000
| -5% | -$1.22M |
2014 Q2
3 quarters
|
|
191
DELISTED
CIRCOR International, Inc
CIR
| $22.5M | 0.02% |
411,500
-365,095
| -47% | -$19.4M |
2013 Q2
7 quarters
|
|
192
Canadian Pacific Kansas City
CP
$76.4B
| $22.5M | 0.02% |
615,150
-1,436,500
| -70% | -$53M |
2013 Q2
7 quarters
|
|
193
Mativ Holdings
MATV
$644M
| $22.2M | 0.02% |
481,200
-19,000
| -4% | -$823K |
2013 Q2
7 quarters
|
|
194
Salesforce
CRM
$203B
| $21.2M | 0.02% |
317,460
+113,300
| +55% | +$7.03M |
2013 Q2
7 quarters
|
|
195
Expro Ltd
XPRO
$1.76B
| $20.9M | 0.02% |
185,917
-200
| -0.1% | -$20.3K |
2013 Q3
6 quarters
|
|
196
DELISTED
Diebold Nixdorf Incorporated
DBD
| $19.9M | 0.02% |
562,000
+35,000
| +7% | +$1.18M |
2013 Q2
7 quarters
|
|
197
NN Inc
NNBR
$327M
| $18M | 0.02% |
717,200
+209,600
| +41% | +$5.01M |
2014 Q1
4 quarters
|
|
198
Range Resources
RRC
$9.68B
| $17.7M | 0.02% |
340,650
+1,850
| +0.5% | +$91.8K |
2013 Q2
7 quarters
|
|
199
DELISTED
Novadaq Technologies Inc.
NVDQ
| $17.6M | 0.02% |
1,085,082
+325,000
| +43% | +$4.83M |
2014 Q4
1 quarter
|
|
200
Willis Towers Watson
WTW
$28.8B
| $16.8M | 0.02% |
131,446
-637,015
| -83% | -$78.2M |
2013 Q2
7 quarters
|
|
Similar funds
Primecap Management's Q1 2015 Portfolio in Review
As of Q1 2015, Primecap Management held 266 positions worth $102B, up 3.8% from $98.7B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Primecap Management's Q1 2015 filing shows 6 new, 123 increased, 91 reduced and 9 closed positions. Its largest new stake was JPMorgan Chase: 2,503,701 shares worth $152M. The largest sale was Biogen, an estimated $241M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q1 2015 buy was JPMorgan Chase: 2,503,701 shares worth $152M.
- Primecap Management added most to NetApp in Q1 2015, an estimated $584M increase.
- Primecap Management's biggest Q1 2015 reduction was Biogen, cutting an estimated $241M.
- Primecap Management fully exited Luminex Corp in Q1 2015, selling an estimated $35.7M.
- Primecap Management's ten largest holdings make up 36% of its $102B portfolio in Q1 2015.
- Primecap Management opened 6 new positions and closed 9 in Q1 2015.
- Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $102B.
Based on Primecap Management's 13F filing for Q1 2015, filed 14 May 2015.